PRESS RELEASE published on 11/22/2023 at 15:00, 2 years ago Rover Metals Holds Meeting with BLM to Discuss and Review Project Description for Let’s Go Lithium Project, NV, USA
PRESS RELEASE published on 10/18/2023 at 08:17, 2 years 1 month ago Original-Research: Rover Metals Corp. (von Sphene Capital GmbH): Buy
PRESS RELEASE published on 10/05/2023 at 15:00, 2 years 1 month ago Rover Metals Adds 2,400 Acres to Let’s Go Lithium Project, NV, USA
PRESS RELEASE published on 09/26/2023 at 15:00, 2 years 2 months ago Rover Metals Announces the Appointment of McGinley and Associates for Its NEPA Permitting Process at the LGL Project, NV, USA
PRESS RELEASE published on 09/07/2023 at 15:00, 2 years 2 months ago Rover Metals Announces Results of Expanded Phase 1 Surface Exploration Program at Its LGL Lithium Project, Nevada, USA
PRESS RELEASE published on 09/05/2023 at 15:00, 2 years 2 months ago Rover Metals Closes $0.08 Unit Financing
PRESS RELEASE published on 08/03/2023 at 11:11, 2 years 4 months ago Original-Research: Rover Metals Corp. (von Sphene Capital GmbH): Buy
Published on 12/05/2025 at 02:35, 3 hours 23 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 4 hours 58 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 53 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 58 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 28 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 7 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 33 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 43 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 47 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 11 hours 58 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 13 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 14 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 57 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago Declaration of voting rights at the end of November 2025
